Worldwide Ebitda from 2010 to 2025

WWH Stock   329.50  1.00  0.30%   
Worldwide Healthcare's EBITDA is increasing over the years with stable fluctuation. Overall, EBITDA is expected to go to about 246.3 M this year. During the period from 2010 to 2025 Worldwide Healthcare EBITDA annual values regression line had coefficient of variation of  125.59 and r-squared of  0.04. View All Fundamentals
 
EBITDA  
First Reported
2003-09-30
Previous Quarter
-953 K
Current Value
-953 K
Quarterly Volatility
56.9 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Worldwide Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Worldwide Healthcare's main balance sheet or income statement drivers, such as Interest Expense of 9.8 M, Selling General Administrative of 19.6 M or Total Revenue of 284 M, as well as many indicators such as . Worldwide financial statements analysis is a perfect complement when working with Worldwide Healthcare Valuation or Volatility modules.
  
This module can also supplement various Worldwide Healthcare Technical models . Check out the analysis of Worldwide Healthcare Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Worldwide Stock

Worldwide Healthcare financial ratios help investors to determine whether Worldwide Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Worldwide with respect to the benefits of owning Worldwide Healthcare security.